Futamura T, Shimokawa T, Morio Y, Haga K, Fukuda T
Research Laboratories, Yoshitomi Pharmaceutical Industries, Ltd., Fukuoka, Japan.
Nihon Yakurigaku Zasshi. 1995 Nov;106(5):339-46. doi: 10.1254/fpj.106.339.
The affinity of mosapramine, an iminodibenzyl antipsychotic, to dopamine D3-receptors in rat brain was investigated by quantitative autoradiography of [3H]-7-OH-DPAT, a selective D3-ligand. Autoradiograms showed restricted distribution of [3H]7-OH-DPAT binding sites, with very high levels on the islands of Calleja (ICj), olfactory tubercle (Tu) and nucleus accumbens, while low but distinct labeling was observed in the molecular layer of lobule 10 of the cerebellum and caudate putamen (CPu). Binding of [3H]7-OH-DPAT completely disappeared when 1 microM dopamine was added, and it was reduced by the addition of mosapramine in a concentration-dependent manner. The displacing effect of mosapramine was more potent than that of haloperidol or clozapine in the brain regions examined. Mosapramine showed more potent affinity to receptors in Tu and ICj than those in CPu. On the other hand, haloperidol and clozapine did not show such regional differences. These results suggest that the high affinity of mosapramine to D3-receptors participates in, at least in part, the development of the clinical effects of mosapramine.
采用选择性D3配体[3H]-7-OH-DPAT定量放射自显影法,研究了亚氨基二苄基抗精神病药物莫沙必利对大鼠脑内多巴胺D3受体的亲和力。放射自显影片显示,[3H]7-OH-DPAT结合位点分布局限,在Calleja岛(ICj)、嗅结节(Tu)和伏隔核中水平极高,而在小脑第10小叶分子层和尾状壳核(CPu)中虽有低水平但明显的标记。加入1 microM多巴胺后,[3H]7-OH-DPAT的结合完全消失,加入莫沙必利后其结合以浓度依赖方式降低。在所研究的脑区中,莫沙必利的置换作用比氟哌啶醇或氯氮平更强。莫沙必利对Tu和ICj中的受体的亲和力比对CPu中的受体更强。另一方面,氟哌啶醇和氯氮平未表现出这种区域差异。这些结果表明,莫沙必利对D3受体的高亲和力至少部分参与了莫沙必利临床效应的产生。